AOD9604 - 5mg
AOD9604 - 5mg
For research purposes only – no human use.
AOD9604 5mg
AOD9604 5mg is supplied strictly as a laboratory research peptide for analytical and scientific use only. Available to qualified researchers, laboratories, and institutions in Perth and across Western Australia, with Australian-based fulfilment.
Intended for in-vitro research, assay development, method validation, and controlled scientific investigation conducted by appropriately qualified professionals.
Product details
- Product: AOD 9604
- Molecular Formula: C78H123N23O23S2
- Strength / size: 5 mg
- Category: Research peptide / laboratory compound
- Use: Laboratory research only
- Certification: Certificate of Analysis (COA) / batch documentation (where available)
-
Supply: Perth & Western Australia (AU shipping)
SEQUENCE: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
AOD 9604 is a modified peptide initially developed as an offshoot in obesity research. It modifies the peptide Fragment 176-191 f the growth hormone hGH by adding a tyrosine residue to the N-terminus. The proposed mode of action of AOD 9604 has been suggested by researchers to be restricted to promoting lipolysis, thus linking the synthetic compound to obesity research. The peptide does not appear to affect levels of insulin or IGF1 in studies thus far; therefore, it does not appear to trigger diabetes development or induce glucose intolerance in test models, though further studies are necessary to explore this aspect.
Important research use notice*
- Not for human consumption
- Not for clinical, therapeutic, or diagnostic use
- Not for veterinary use
- No health, medical, or performance claims are made or implied
By purchasing, the buyer confirms this item will be used solely for legitimate laboratory research in accordance with applicable Australian laws and regulations.
